Home › Funds › Aptus Capital Advisors, LLC › JNJ

Aptus Capital Advisors, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

Aptus Capital Advisors, LLC reported holding 197,008 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$52.2M, representing 0.45% of its reported portfolio and ranking #43 among its reported holdings. Aptus Capital Advisors, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)197.01K sh
Reported value held$52.16M
Portfolio Weight0.45%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Aptus Capital Advisors, LLC's JNJ position evolved

Aptus Capital Advisors, LLC first disclosed a stake in JNJ in Q3 2023 at 82,583 shares (US$12.9M). The position peaked in Q3 2026 at 197,008 shares, worth US$52.2M. Across 13 filings, Aptus Capital Advisors, LLC increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 197,008 shares valued at US$52.2M — a reduction of -4,683 shares quarter over quarter.. Notable position changes include a 40% increase in Q3 2024 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 82.58K $12.86M New
Q4 2023 74.23K $11.64M Reduce
Q1 2024 84.63K $13.39M Add
Q2 2024 104.50K $15.27M Add
Q3 2024 146.56K $23.75M Add
Q4 2024 169.26K $24.48M Add
Q1 2025 156.51K $25.95M Reduce
Q2 2025 162.48K $24.82M Add
Q3 2025 164.39K $30.48M Add
Q4 2025 199.22K $41.23M Add
Q1 2026 193.14K $47.21M Reduce
Q2 2026 201.69K $51.22M Add
Q3 2026 197.01K $52.16M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Aptus Capital Advisors, LLC held JNJ?

Aptus Capital Advisors, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Aptus Capital Advisors, LLC's current position in JNJ?

As of Q3 2026, Aptus Capital Advisors, LLC holds 197.01K shares of JNJ (JOHNSON & JOHNSON), valued at $52.16M, representing 0.45% of its reported portfolio and ranking #43.

Has Aptus Capital Advisors, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Aptus Capital Advisors, LLC reduced its position in JNJ. The position peaked in Q3 2026 at 197.01K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.